The accrued data from the Phase 3 study suggest that the baseline characteristics of the enrolled patients are consistent with those observed in previous studies
We are building an AI-native operating system for pharma sales and distribution
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
IIT Kanpur team has developed computational framework to map how cell signals influence gene activity across tissues
In the new study, scientists at the University of Virginia used gene-editing techniques to modify GLP-1 receptors in mice to make them more humanlike
Bengaluru startup targets 100+ enterprise clients and global expansion as it aims to transform pharmaceutical sales, marketing, tenders, and distribution using AI agents
The once-daily oral therapy is the first and only tyrosine kinase 2 (TYK2) inhibitor approved in the European Union for this indication, marking a significant expansion of its immunology portfolio
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
Expands manufacturing push & locks in major growth deals
Subscribe To Our Newsletter & Stay Updated
